Luye Pharma Group Ltd.

HKEX:2186.HK

3.02 (HKD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Omzet 6,143.0785,981.6565,200.2265,539.6416,357.5965,173.3853,814.8422,917.7942,563.1293,154.222,515.1112,135.9431,774.391,340.895954.75650.976508.98308.294344.368315.4238.071
Kosten van de omzet 1,938.9031,841.141,803.4861,549.0271,478.6841,123.971851.484535.047475.717482.505413.506351.813301.121204.247135.96485.88780.16963.48576.493104.984107.989
Brutowinst 4,204.1754,140.5163,396.743,990.6144,878.9124,049.4142,963.3582,382.7472,087.4122,671.7152,101.6051,784.131,473.2691,136.648818.786565.089428.811244.809267.875210.416130.082
Brutowinstmarge 0.6840.6920.6530.720.7670.7830.7770.8170.8140.8470.8360.8350.830.8480.8580.8680.8420.7940.7780.6670.546
Onderzoek- en ontwikkelingskosten 586.157857.337683.156789.869579.455491.16288.696193.656170.439182.332194.081134.368000000000
Algemene en administratieve kosten 643.967582.87570.844521.482525.921441.377431.635267.039184.821194.984146.508153.113151.566111.60682.83285.05976.76632.40221.63818.29112.458
Verkoop- en marketingkosten 2,056.1671,819.6911,704.781,663.8932,034.8241,685.9271,286.5451,121.626964.0971,616.4931,378.0611,209.717980.111761.788526.763364.291246.827129.555145.71500
Verkoop-, algemene en administratieve kosten 2,700.1342,402.5612,275.6242,185.3752,560.7452,127.3041,718.181,388.6651,148.9181,811.4771,524.5691,367.6231,131.677873.394609.595449.35323.593161.957167.35318.29112.458
Overige kosten 0.284-73.26155.154-199.893-121.0417.8093.8833.1463.2590.668-0.2260126.1961.06311.57412.978-10.0274.879-1.005-6.293-6.88
Bedrijfskosten 3,175.453,186.6383,113.9342,775.3513,019.1592,532.6021,872.5161,468.0361,256.4531,946.851,687.8111,504.6381,257.873934.756656.804484.242351.813164.204176.489128.39672.106
Bedrijfsresultaat 887.4381,214.982386.9871,418.9561,989.9131,516.8121,090.8421,203.0761,103.626764.827406.269275.002215.396201.892161.98280.84776.99880.60591.38682.0257.976
Bedrijfsresultaat ratio 0.1440.2030.0740.2560.3130.2930.2860.4120.4310.2420.1620.1290.1210.1510.170.1240.1510.2610.2650.260.244
Totaal overige inkomsten en kosten netto -187.338-545.22-461.544-476.782-218.258-43.34225.47960.01167.1730.649-30.626-19.551-14.268-6.4724.2271.938-10.0274.879-1.005-6.293-6.88
Inkomen voor belasting 700.1669.762-74.557942.1741,771.6551,473.471,116.321974.722898.132725.514383.168255.451201.128195.42166.20982.78566.97185.48490.38175.72751.096
Inkomen voor belasting ratio 0.1140.112-0.0140.170.2790.2850.2930.3340.350.230.1520.120.1130.1460.1740.1270.1320.2770.2620.240.215
Belastingkosten 161.02386.46670.226238.909279.829167.475135.75680.727133.433111.06855.22479.86234.90245.01637.04420.7047.994.5720.217-0.5266.319
Nettowinst 532.605604.807-144.783706.5861,468.5621,303.373981.372891.539754.523605.524310.498169.032151.624136.103123.54762.08958.98180.91290.16471.83742.576
Nettowinstmarge 0.0870.101-0.0280.1280.2310.2520.2570.3060.2940.1920.1230.0790.0850.1020.1290.0950.1160.2620.2620.2280.179
WPA (Winst Per Aandeel) 0.140.17-0.0420.220.460.410.30.270.230.20.630.340.310.280.250.130.120.180.220.240.13
Verwaterde WPA 0.140.17-0.0420.220.460.40.30.270.230.20.630.340.310.280.250.130.120.180.220.240.13
EBITDA 1,894.8191,886.295968.9691,929.8552,431.9441,943.5141,352.2621,113.739955.31870.133514.586353.51299.715276.954220.95196.993118.18495.714103.10893.08468.283
EBITDA ratio 0.3080.3150.1860.3480.3830.3760.3540.3820.3730.2760.2050.1660.1690.2070.2310.1490.2320.310.2990.2950.287